The recent dreadful performance of the academic Value equity factor has been a blow for many investors. Even prominent quants seem to have thrown in the towel on Value and factor investing quant in general.1 But are recent developments really enough to dismiss the Value factor altogether? We don’t think so.
For one, the recent poor performance of Fama-French style value stocks still falls within the statistical range of possible outcomes. And while it is true that classic value strategies performed poorly in equity markets, this has clearly not been the case for other asset classes. In corporate bond markets, for instance, value has been a clear source of outperformance over the past five years.
Admittedly, such arguments do not fully alleviate concerns that the value equity factor may be impaired, or perhaps even obsolete. This is why, in a new study,2 we address this concern. We show that the classic definition of value can be resurrected by adopting a more sophisticated approach, which, in turn, enhances the academic approach.
While most investors have focused on the most recent period of underperformance, we have found that the standard Fama-French value factor, based on book-to-market metrics, has not only suffered setbacks in recent years, but has been struggling for decades. This is consistent with the widespread view among academics that the classic value equity factor is now outmoded.
Our research shows that using more powerful value metrics, applying basic risk management techniques and using the breadth of the liquid universe of stocks more effectively, leads to much better investment results. Although this improved value strategy has also suffered in recent years, it has a solid long-term track record that does not warrant existing concerns.
More specifically, we augment the book-to-market ratio with three alternative value signals namely: Ebitda/EV,3 cashflow-to-price and net payout yield. These three metrics all have in common that they do not rely on balance sheet information, such as book-to-market, but are based on earnings and cashflows and therefore less sensitive to accounting assumptions.
We augment the book-to-market ratio with three alternative value signals
In terms of risk management, we seek to avoid the large persistent industry or regional bets that the standard value factor takes, given that certain industries and regions are structurally cheaper than others. We are therefore region and industry neutral in developed markets. In emerging markets, we apply country neutrality, as countries are the primary risk factor in these markets.
Finally, we strive to make full use of the breadth the global equity market offers. The standard value factor gives a disproportionately high weight of 50% to small-cap stocks, which only comprise 10% of total market capitalization. At the same time, it also uses capitalization-weighting to prevent these numerous and extremely small stocks from dominating the result.
However, this approach does not prevent overexposure to a small group of very large caps, nor does it fully remove smaller illiquid stocks from the universe. Our approach addresses these issues by focusing solely on the liquid large and mid-cap stocks, while using an equally-weighted allocation scheme to make full use of the breadth this universe of liquid stocks has to offer.
Ultimately, our more sophisticated value equity factor uses ideas that have been well documented in the literature or that are common knowledge among practitioners. We therefore conclude that, with a bit of effort, a significant value premium can still be found in the cross-section of stock returns.
This report is not available for users from countries where the offering of foreign financial services is not permitted, such as US Persons.
Your details are not shared with third parties. This information is exclusively intended for professional investors. All requests are checked.
The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients.
The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA).
Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile.
Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports.